novo glp-1 drug Nordisk's oral didn't work on Alzheimer's as hoped, but don't call it a failure GLP-1 drugs protect against new
Description
These drugs are produced by Novo Nordisk and Eli Lilly, which both recently announced agreements with the Trump administration to lower prices
Tirzepatide versus semaglutide for weight loss: a meta-analysis of randomized controlled trials
Most people lose weight with continued treatment after a few months
95% CI, -0.82% to -0.13%) while maintaining stable kidney function
